Top Markets
#1 Islamic Coin Islamic Coin +154.32%
#2 PulseChain PulseChain +49.10%
#3 DogBull DogBull +34.89%
#4 BOOK OF MEME BOOK OF MEME +34.12%
#5 rsERG rsERG +20.54%
#6 Ergo Ergo +19.46%
#7 Bio Protocol Bio Protocol +16.01%
#8 Janction Janction +14.10%
#9 Victoria VR Victoria VR +13.92%
#10 RedStone RedStone +13.84%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Neurizon Therapeutics Limited Neurizon Therapeutics Limited

Neurizon Therapeutics Limited

NUZ
Clasificación en acciones #27536
Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops... Neurizon Therapeutics Limited, a clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases. The company develops drug discovery intellectual property for the treatment of neurological diseases. Its lead candidate is NUZ-001, a small molecule drug which is in Phase II clinical trials for the treatment of amyotrophic lateral sclerosis, as well as to treat other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Precio por acción
$0.0416118
Capitalización bursátil
$32.25M
Cambio (1 día)
-1.67%
Cambio (1 año)
-59.58%
País
AU
Comercio Neurizon Therapeutics Limited (NUZ)

Categoría

Healthcare
Ingresos de Neurizon Therapeutics Limited (NUZ)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Neurizon Therapeutics Limited, los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Neurizon Therapeutics Limited desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH